|
Oligodendroglioma Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 91 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, H1, 2012" provides data on the Oligodendroglioma clinical trial scenario. This report provides eleme.....
Introduction GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, H1, 2012" provides data on the Oligodendroglioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Oligodendroglioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Oligodendroglioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Oligodendroglioma 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials by Country 8 Top Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Clinical Trials by BRIC Nations 13 Clinical Trials by G7 Nations 14 Clinical Trials in G7 Nations by Trial Status 15 Clinical Trials by E7 Nations 16 Clinical Trials in E7 Nations by Trial Status 17 Clinical Trials by Phase 18 In Progress Trials by Phase 19 Clinical Trials by Trial Status 20 Unaccomplished Trials of Oligodendroglioma 21 Subjects Recruited Over a Period of Time 23 Prominent Sponsors 24 Top Companies Participating in Oligodendroglioma Therapeutics Clinical Trials 26 Prominent Drug Comparison 27 Clinical Trial Profiles 28 Clinical Trial Overview of Top Companies 28 Tocagen Inc. 28 Clinical Trial Overview of Tocagen Inc. 28 TransMolecular, Inc. 29 Clinical Trial Overview of TransMolecular, Inc. 29 AOI Pharmaceuticals, Incorporated 30 Clinical Trial Overview of AOI Pharmaceuticals, Incorporated 30 INSYS Therapeutics, Inc. 31 Clinical Trial Overview of INSYS Therapeutics, Inc. 31 Teva Pharmaceuticals USA, Inc. 32 Clinical Trial Overview of Teva Pharmaceuticals USA, Inc. 32 Pharmacyclics, Inc. 33 Clinical Trial Overview of Pharmacyclics, Inc. 33 Clinical Trial Overview of Top Universities / Institutes / Hospitals 34 City of Hope National Medical Center 34 Clinical Trial Overview of City of Hope National Medical Center 34 Case Comprehensive Cancer Center 35 Clinical Trial Overview of Case Comprehensive Cancer Center 35 Dana-Farber Cancer Institute 36 Clinical Trial Overview of Dana-Farber Cancer Institute 36 Wake Forest University 37 Clinical Trial Overview of Wake Forest University 37 University of California, San Francisco 38 Clinical Trial Overview of University of California, San Francisco 38 University of Pittsburgh 39 Clinical Trial Overview of University of Pittsburgh 39 Ohio State University Comprehensive Cancer Center 40 Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 40 Les Hopitaux Universitaires de Strasbourg 41 Clinical Trial Overview of Les Hopitaux Universitaires de Strasbourg 41 European Organization for Research and Treatment of Cancer 42 Clinical Trial Overview of European Organization for Research and Treatment of Cancer 42 Abramson Cancer Center 43 Clinical Trial Overview of Abramson Cancer Center 43 Memorial Sloan Kettering Cancer Center 44 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 44 Ludwig-Maximilians-Universitat Munich 45 Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich 45 Northwestern University 46 Clinical Trial Overview of Northwestern University 46 University of California, Los Angeles 47 Clinical Trial Overview of University of California, Los Angeles 47 Sun Yat-sen University 48 Clinical Trial Overview of Sun Yat-sen University 48 Radiation Therapy Oncology Group 49 Clinical Trial Overview of Radiation Therapy Oncology Group 49 Roswell Park Cancer Institute 50 Clinical Trial Overview of Roswell Park Cancer Institute 50 Weill Cornell Medical College 51 Clinical Trial Overview of Weill Cornell Medical College 51 Hopitaux Universitaires de Geneve 52 Clinical Trial Overview of Hopitaux Universitaires de Geneve 52 H. Lee Moffitt Cancer Center & Research Institute 53 Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 53 Five Key Clinical Profiles 54 Appendix 87 Abbreviations 87 Definitions 87 Research Methodology 89 Secondary Research 89 About GlobalData 90 Contact Us 90 Disclaimer 90 Source 91 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7 Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 Oligodendroglioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10 Oligodendroglioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11 Oligodendroglioma Therapeutics Clinical Trials, North America, Top Countries, 2012* 12 Oligodendroglioma Therapeutics Clinical Trials, BRIC Countries, 2012* 13 Oligodendroglioma Therapeutics Clinical Trials, G7 Countries, 2012* 14 Oligodendroglioma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15 Oligodendroglioma Therapeutics Clinical Trials, E7 Countries, 2012* 16 Oligodendroglioma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 17 Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Phase, 2012* 18 Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 19 Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 20 Oligodendroglioma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 21 Oligodendroglioma Therapeutics Market, Global, Terminated Clinical Trials, 2012* 22 Oligodendroglioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 23 Oligodendroglioma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25 Oligodendroglioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26 Oligodendroglioma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 27 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tocagen Inc., 2012* 28 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by TransMolecular, Inc., 2012* 29 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by AOI Pharmaceuticals, Incorporated, 2012* 30 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by INSYS Therapeutics, Inc., 2012* 31 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceuticals USA, Inc., 2012* 32 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2012* 33 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012* 34 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 35 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 36 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 37 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 38 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 39 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2012* 40 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Les Hopitaux Universitaires de Strasbourg, 2012* 41 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012* 42 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012* 43 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 44 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig-Maximilians-Universitat Munich, 2012* 45 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 46 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012* 47 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012* 48 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2012* 49 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 50 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012* 51 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2012* 52 Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012* 53 List of Figures Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7 Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 Oligodendroglioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10 Oligodendroglioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11 Oligodendroglioma Therapeutics Clinical Trials, G7 Countries (%), 2012* 14 Oligodendroglioma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15 Oligodendroglioma Therapeutics Clinical Trials, E7 Countries (%), 2012* 16 Oligodendroglioma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 17 Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 18 Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 19 Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 20 Oligodendroglioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 23 Oligodendroglioma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24 Oligodendroglioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26 Oligodendroglioma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 27 GlobalData Methodology 89 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
